Literature DB >> 6249759

Chemotaxin-induced changes in cyclic adenosine monophosphate levels in human neutrophils.

R S Marx, C E McCall, D A Bass.   

Abstract

Incubation of the chemotactic agent N-formyl-methionyl-leucyl-phenylalanine with human neutrophils produced a rapid elevation of the intracellular level of cyclic adenosine monophosphate (cAMP). This cAMP spike occurred within 30 s after exposure and returned to normal by 5 min.

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 6249759      PMCID： PMC551110          DOI： 10.1128/iai.29.1.284-286.1980

Source DB:  PubMed          Journal:  Infect Immun        ISSN： 0019-9567            Impact factor:   3.441


  15 in total

1.  Yin/Yang modulation of lysosomal enzyme release from polymorphonuclear leukocytes by cyclic nucleotides.

Authors:  G Weissmann; I Goldstein; S Hoffstein; G Chauvet; R Robineaux
Journal:  Ann N Y Acad Sci       Date:  1975-06-13       Impact factor: 5.691

2.  Independent stimulation of motility and the oxidative metabolic burst of human polymorphonuclear leukocytes.

Authors:  D A Bass; L R Dechatelet; C E McCall
Journal:  J Immunol       Date:  1978-07       Impact factor: 5.422

3.  The role of calcium and cyclic adenosine 3',5'-monophosphate in the regulation of glycogen metabolism in phagocytozing human polymorphonuclear leukocytes.

Authors:  T Herlin; C S Petersen; V Esmann
Journal:  Biochim Biophys Acta       Date:  1978-08-03

4.  Neutrophil aggregation and swelling induced by chemotactic agents.

Authors:  J T O'Flaherty; D L Kreutzer; P A Ward
Journal:  J Immunol       Date:  1977-07       Impact factor: 5.422

5.  N-formylmethionyl peptides as chemoattractants for leucocytes.

Authors:  E Schiffmann; B A Corcoran; S M Wahl
Journal:  Proc Natl Acad Sci U S A       Date:  1975-03       Impact factor: 11.205

6.  Substances which aggregate neutrophils. Mechanism of action.

Authors:  J T O'Flaherty; H J Showell; E L Becker; P A Ward
Journal:  Am J Pathol       Date:  1978-07       Impact factor: 4.307

7.  In vitro stimulation of neutrophil motility by levamisole: maintenance of cgmp levels in chemotactically stimulated levamisole-treated neutrophils.

Authors:  R Anderson; A Glover; H J Koornhof; A R Rabson
Journal:  J Immunol       Date:  1976-08       Impact factor: 5.422

8.  Specific receptor sites for chemotactic peptides on human polymorphonuclear leukocytes.

Authors:  L T Williams; R Snyderman; M C Pike; R J Lefkowitz
Journal:  Proc Natl Acad Sci U S A       Date:  1977-03       Impact factor: 11.205

9.  A simplified procedure for cyclic nucleotide radioimmunoassay and its application to human blood leukocytes.

Authors:  G E Hatch; W K Nichols; H R Hill
Journal:  J Immunol Methods       Date:  1978       Impact factor: 2.303

10.  The structure-activity relations of synthetic peptides as chemotactic factors and inducers of lysosomal secretion for neutrophils.

Authors:  H J Showell; R J Freer; S H Zigmond; E Schiffmann; S Aswanikumar; B Corcoran; E L Becker
Journal:  J Exp Med       Date:  1976-05-01       Impact factor: 14.307
View more
  4 in total

1.  Cholera toxin inhibits chemotaxis by a cAMP-independent mechanism.

Authors:  R R Aksamit; P S Backlund; G L Cantoni
Journal:  Proc Natl Acad Sci U S A       Date:  1985-11       Impact factor: 11.205

2.  Pertussis toxin inhibition of chemotaxis and the ADP-ribosylation of a membrane protein in a human-mouse hybrid cell line.

Authors:  P S Backlund; B D Meade; C R Manclark; G L Cantoni; R R Aksamit
Journal:  Proc Natl Acad Sci U S A       Date:  1985-05       Impact factor: 11.205

3.  Cyclic nucleotide changes induced in human leukocytes by a product of axenically grown Entamoeba histolytica that inhibits human monocyte locomotion.

Authors:  G Rico; O Díaz-Guerra; R R Kretschmer
Journal:  Parasitol Res       Date:  1995       Impact factor: 2.289

4.  Guanine nucleotides modulate the binding affinity of the oligopeptide chemoattractant receptor on human polymorphonuclear leukocytes.

Authors:  C Koo; R J Lefkowitz; R Snyderman
Journal:  J Clin Invest       Date:  1983-09       Impact factor: 14.808
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.